Fractyl Stock

fractyl.comHealthcareFounded: 2010Funding to Date: $286.48MM

Fractyl ais a biotechnology company looking to bring curative therapies to the large populations of patients with metabolic disease.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Fractyl, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Fractyl.

Register Today
Register for Details

For more details on financing and valuation for Fractyl, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Harith Rajagopalan Ph.D
Co-Founder, Chief Executive Officer and Board Member
Lisa Davidson
Chief Financial Officer
Jay Caplan
President, Board Member & Co-Founder
Diane Marcou
Chief Financial Officer
David Maggs
Chief Medical Officer

Board Members

Ajay Royan
Mithril Capital Management
Allan Will
Brian Dovey
Domain Associates
Christopher Gabrieli MD
Bessemer Venture Partners
Harith Rajagopalan Ph.D
Hemant Taneja
General Catalyst
Jay Caplan
John Amatruda
Stanley Lapidus
William Bradley

Other companies like Fractyl in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$1.33B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$67.5MM
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$8.18B

News

Fractyl Laboratories Inc., a Lexington, Mass.-based developer of minimally invasive procedural therapy that can reverse metabolic diseases, completed a $44m Series D financing. The round was led by an undisclosed new investor, joined by new investors GV, True Ventures, and the IDO Fund and returning investors General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital …